← Open Payments lookup

SHEELA GADE: Open Payments

NPI 1114143757 · SAN MARINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$881 in 35 payments from 16 companies in 2025. Trend: 2023 $608 · 2024 $283 · 2025 $881

Food & beverage: $881
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$151
ABBVIE INC.8$139
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$86
Bausch Health US, LLC4$81
Collegium Pharmaceutical, Inc.4$77
Vanda Pharmaceuticals Inc.2$72
Teva Pharmaceuticals USA, Inc.3$67
Janssen Pharmaceuticals, Inc1$35
Corium, LLC1$32
Neurocrine BioSciences, Inc.1$27

Products named: COBENFY, VRAYLAR, CAPLYTA, APLENZIN, Jornay PM, HETLIOZ, UZEDY, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.